Compare Enveric Biosciences Inc (ENVB) vs Norwegian Cruise Line Holdings Ltd (NCLH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Norwegian Cruise Line Holdings Ltd — how do they compare? Enveric Biosciences Inc trades at $1.45 (market cap $6.20M), while Norwegian Cruise Line Holdings Ltd trades at $18.87 (market cap $8.59B). The key difference: Norwegian Cruise Line Holdings Ltd is far larger — about 1385.5× Enveric Biosciences Inc's market cap, and Norwegian Cruise Line Holdings Ltd is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | NCLH | |
|---|---|---|
Market Cap | $6.20M | $8.59B |
Sector | Health | Consumer Cyclical |
52-Week High | $17.40 | $26.94 |
52-Week Low | $1.27 | $14.79 |
Enterprise Value | $1.30M | $23.40B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Norwegian Cruise Line Holdings Ltd
Norwegian Cruise Line is the world's third-largest cruise company by berths (at more than 62,000), operating 29 ships across three brands (Norwegian, Oceania, and Regent Seven Seas), offering both freestyle and luxury cruising. The company has redeployed its entire fleet as of May 2022. With eight passenger vessels on order among its brands through 2027 (representing 20,000 incremental berths), Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sailed to around 500 global destinations before the pandemic.
Read more on NCLH →
